PCSK9 inhibitors: a patent review 2018-2023-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PCSK9 inhibitors: a patent review 2018-2023

Published:2024-04-02 Issue:4 Volume:34 Page:245-261
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Fassi Enrico Mario Alessandro¹,Citarella Andrea²,Albani Marco¹,Milano Erica Ginevra¹,Legnani Laura³,Lammi Carmen¹,Silvani Alessandra²,Grazioso Giovanni¹

Affiliation:

1. Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Milano, Italy

2. Dipartimento di Chimica, Università degli Studi di Milano, Milano, Italy

3. Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Milano, Italy

Funder

Linea2

University of Milan

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2024.2340569

Reference65 articles.

1. Hypercholesterolemia, low density lipoprotein receptor andproprotein convertase subtilisin/kexin-type 9

2. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

3. Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline

4. Resistance and intolerance to statins

5. Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP